Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
Lrp4 is a multifunctional member of the low density lipoprotein-receptor gene family and a modulator of extracellular cell signaling pathways in development. For example, Lrp4 binds Wise, a secreted Wnt modulator and BMP antagonist. Lrp4 shares structural elements within the extracellular ligand bin...
Main Authors: | Hong Y Choi, Marco Dieckmann, Joachim Herz, Andreas Niemeier |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-11-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2775917?pdf=render |
Similar Items
-
Evaluation of the relationship between inflammation and bone turnover by sclerostin and Dickkopf-1 (DKK-1) levels in patients with SIRS
by: Mehmet Aşık, et al.
Published: (2022-07-01) -
Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo
by: Whitney A. Bullock, et al.
Published: (2019-10-01) -
Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
by: Vladimir Gerov, et al.
Published: (2023-07-01) -
Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.
by: Maarten van Dinther, et al.
Published: (2013-01-01) -
Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
by: Yentl Huybrechts, et al.
Published: (2023-01-01)